1 dose; 2doses (2-6monthsapart) ifimmunocomp75y.o.≥ 100mg/dLovariancancer60y.o.≥20%< 60y.o.HepatitisBinsufficientevidenceforscreening52y.o.40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsdyslipidemia40-59 y.o.,ASCVD ≥10%, lowbleeding riskHIV3%40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factorcolorectalcancer50y.o.community-dwelling,postmenopausalwomen65y.o.Gailmodelaspirinaromataseinhibitorscervicalcancerq2yoverweight/ obesity40-70 y.o.,ASCVD ≥10%, lowbleeding risk≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsdepression≥5.7%FractureRiskAssessmentToolPREVENTequation≥6.5%herpeszosterlungcancerq1y≤q2yanxietyraloxifeneq3ybreastcancerq1-2ymammogrambased on lifeexpectancy /health statuscardiovasculardiseaseTimedup andgo testtobaccouse40y.o.≥ 200mg/dL2 doses,2-6monthsaparthormonetherapyq15ydiabetesHepatitisC≥ 126mg/dLmultidoseinitial series,then 1 doseat 2-6monthsdementiatamoxifenhypertensionq5yq1ymammogramTyrer-Cuzickmodelstatin≥ 140mg/dL40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factorwomenage 55-64 y.o.pneumococcal1 dose; 2doses (2-6monthsapart) ifimmunocomp75y.o.≥ 100mg/dLovariancancer60y.o.≥20%< 60y.o.HepatitisBinsufficientevidenceforscreening52y.o.40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsdyslipidemia40-59 y.o.,ASCVD ≥10%, lowbleeding riskHIV3%40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factorcolorectalcancer50y.o.community-dwelling,postmenopausalwomen65y.o.Gailmodelaspirinaromataseinhibitorscervicalcancerq2yoverweight/ obesity40-70 y.o.,ASCVD ≥10%, lowbleeding risk≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsdepression≥5.7%FractureRiskAssessmentToolPREVENTequation≥6.5%herpeszosterlungcancerq1y≤q2yanxietyraloxifeneq3ybreastcancerq1-2ymammogrambased on lifeexpectancy /health statuscardiovasculardiseaseTimedup andgo testtobaccouse40y.o.≥ 200mg/dL2 doses,2-6monthsaparthormonetherapyq15ydiabetesHepatitisC≥ 126mg/dLmultidoseinitial series,then 1 doseat 2-6monthsdementiatamoxifenhypertensionq5yq1ymammogramTyrer-Cuzickmodelstatin≥ 140mg/dL40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factorwomenage 55-64 y.o.pneumococcal

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
  1. 1 dose; 2 doses (2-6 months apart) if immunocomp
  2. 75 y.o.
  3. ≥ 100 mg/dL
  4. ovarian cancer
  5. 60 y.o.
  6. ≥ 20%
  7. < 60 y.o.
  8. Hepatitis B
  9. insufficient evidence for screening
  10. 52 y.o.
  11. 40-75 y.o., LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  12. dyslipidemia
  13. 40-59 y.o., ASCVD ≥ 10%, low bleeding risk
  14. HIV
  15. 3%
  16. 40-75 y.o., ASCVD ≥ 7.5%, ≥ 1 risk factor
  17. colorectal cancer
  18. 50 y.o.
  19. community-dwelling, postmenopausal women
  20. 65 y.o.
  21. Gail model
  22. aspirin
  23. aromatase inhibitors
  24. cervical cancer
  25. q2y
  26. overweight / obesity
  27. 40-70 y.o., ASCVD ≥ 10%, low bleeding risk
  28. ≥ 40 y.o.; LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  29. depression
  30. ≥ 5.7%
  31. Fracture Risk Assessment Tool
  32. PREVENT equation
  33. ≥ 6.5%
  34. herpes zoster
  35. lung cancer
  36. q1y
  37. ≤ q2y
  38. anxiety
  39. raloxifene
  40. q3y
  41. breast cancer
  42. q1-2y mammogram based on life expectancy / health status
  43. cardiovascular disease
  44. Timed up and go test
  45. tobacco use
  46. 40 y.o.
  47. ≥ 200 mg/dL
  48. 2 doses, 2-6 months apart
  49. hormone therapy
  50. q15y
  51. diabetes
  52. Hepatitis C
  53. ≥ 126 mg/dL
  54. multidose initial series, then 1 dose at 2-6 months
  55. dementia
  56. tamoxifen
  57. hypertension
  58. q5y
  59. q1y mammogram
  60. Tyrer-Cuzick model
  61. statin
  62. ≥ 140 mg/dL
  63. 40-75 y.o.; LDL > 190 or ASCVD ≥ 10% + ≥ 1 risk factor
  64. women age 55-64 y.o.
  65. pneumococcal